| |
TRENDS
The Global Market For ADHD Medications
Richard M. Scheffler,
Stephen P. Hinshaw,
Sepideh Modrek and
Peter Levine
Little is known about the global use and cost of medications for attention deficit hyperactivity disorder (ADHD). Global use of ADHD medications rose threefold from 1993 through 2003, whereas global spending (U.S. $2.4 billion in 2003) rose ninefold, adjusting for inflation. Per capita gross domestic product (GDP) robustly predicted use across countries, but the United States, Canada, and Australia showed significantly higher-than-predicted use. Use and spending grew in both developed and developing countries, but spending growth was concentrated in developed countries, which adopted more costly, long-acting formulations. Promoting optimal prescription and monitoring should be a priority.

What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. M. Scheffler, T. T. Brown, B. D. Fulton, S. P. Hinshaw, P. Levine, and S. Stone
Positive Association Between Attention-Deficit/ Hyperactivity Disorder Medication Use and Academic Achievement During Elementary School
Pediatrics,
May 1, 2009;
123(5):
1273 - 1279.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. M. Furman
Attention-Deficit Hyperactivity Disorder (ADHD): Does New Research Support Old Concepts?
J Child Neurol,
July 1, 2008;
23(7):
775 - 784.
[Abstract]
[PDF]
|
 |
|
Comments:
Read all Comments
- Global Perspective On ADHD: Over- And Underuse
- George Halasz
- Health Affairs, 21 Mar 2007
[Full text]
- Response to Global Perspective On ADHD: Over- And Underuse
- Peter L. Levine, et al.
- Health Affairs, 26 Mar 2007
[Full text]
- ADHD Agents: International Comparisons
- Constantine G. Berbatis, et al.
- Health Affairs, 9 May 2007
[Full text]
|